Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
58 items
Small baby sleeping in hospital.

Saving premature babies’ vision with a smartphone camera and artificial intelligence

An inexpensive, smartphone-based camera can help doctors identify premature infants needing treatment for retinopathy of prematurity (ROP), according to a new study funded by the National Eye Institute (NEI).
Brain pathways for visual processing

Scientists discover anatomical changes in the brains of the newly sighted

Following cataract removal, some of the brain’s visual pathways seem to be more malleable than previously thought.

Medical College of Georgia scientists work to protect the vision of premature babies

Augusta University scientists have found a new target and drug that together appear to stop retinopathy of prematurity.

University of Houston researcher builds new model to examine Usher syndrome

Syndrome is a leading cause of combined deafness-blindness

Reading and visual health

Researchers at the State University of New York help explain how reading might contribute to myopia.
blank

FDA-approved drug shows promise in lab models for blinding childhood disease 

A National Eye Institute-led team has identified a compound already approved by the U.S. Food and Drug Administration that keeps light-sensitive photoreceptors alive in three models of Leber congenital amaurosis type 10 (LCA 10).
Two boys smile at camera. The outer portion of the image is darkened, representing vision loss from glaucoma.

New genetic mutation behind childhood glaucoma identified

An international team led by Harvard Medical School scientists has discovered a new genetic mutation that may be a root cause of severe cases of childhood glaucoma, a devastating condition that runs in families.
Fundus photo showing large white patches

Researchers discover new molecular driver of retinoblastoma

Study from UT Southwestern Medical Center could lead to new treatments for deadly childhood eye cancer.
NEI scientists Mitra Farnoodian Tedrick and Kapil Bharti with KTEF Commanders

Knights Templar Eye Foundation funds NEI scientist’s search for therapies to treat blinding eye disease

NEI researcher Mitra Farnoodian Tedrick, Ph.D., received a $65,000 grant from the Knights Templar Eye Foundation (KTEF) to identify drugs to treat a rare blinding condition called Stargardt disease.
Group of cells tinted purple in the middle and pink at the edges representing a human induced stem cell colony from a patient with albinism.

NIH researchers develop first stem cell model of albinism to study related eye conditions

Researchers at the National Eye Institute (NEI) have developed the first patient-derived stem cell model for studying eye conditions related to oculocutaneous albinism (OCA).